Yabao Pharmaceuticals In-licenses China Rights To Parkinson's Drug Technology

Yabao Pharmaceutical in-licensed greater China rights to a Parkinson's disease kinase target from MRC Technology of the UK. MRC Tech describes itself as a charity that operates as a technology transfer unit for the UK's Medical Research Council. After identifying projects with further potential, MRC Tech offers IP management and R&D. MRC Tech will retain rights to the target outside of China, Taiwan and Hong Kong.

Help employers find you! Check out all the jobs and post your resume.